Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Hybridon anti-VEGF antisense compounds for neovascularization disorders

Oct. 25, 1996

NIH offers peptides with OMT residues as potential therapeutic agents

Oct. 25, 1996

Novel APC-based method for producing cancer therapeutics and vaccines available for licensing

Oct. 25, 1996

Human chorionic gonadotropin use in Kaposi's sarcoma described: NIH seeks licensees

Oct. 25, 1996

INSERM claims antitumor antibody

Oct. 25, 1996

SRI and Taiho to develop new approach to breast cancer

Oct. 25, 1996

NIH seeks licensees for dual topoisomerase/tubulin polymerization inhibitor

Oct. 25, 1996

Enzon selects Medac as marketing partner for Oncaspar

Oct. 25, 1996

Isis antisense compound and analogues covered by U.S. patent

Oct. 18, 1996

Targeted Genetics receives grant for its HER-2/neu oncogene inhibitor

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...